Literature DB >> 3003061

Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase.

J D Corbin, D Ogreid, J P Miller, R H Suva, B Jastorff, S O Døskeland.   

Abstract

The specificity of the two intrasubunit cGMP binding sites of cGMP-dependent protein kinase was determined by measuring the ability of 46 cGMP analogs to compete with [3H]cGMP. Both sites of the enzyme exhibited high specificity for the ribose cyclic phosphate moiety, and lower specificity for the guanine moiety. Effects of modifications in the ribose cyclic phosphate moiety suggested that cGMP is bound at both sites by three hydrogen bonds at 2'-OH, 3'-O, and 5'-O. A negative charge in the cyclic phosphate is apparently required. Modifications of the pyrimidine part of guanine, particularly at C-1, generally caused selectivity for the rapidly exchanging site while modifications of the imidazole part of guanine at C-7 and C-8 caused selectivity for the slowly exchanging site. These increases in selectivity for a site were mainly due to losses in affinity of the other site. There was an apparent requirement of the intact amino group at C-2, particularly for the slowly exchanging site. Comparison of the molecular interactions of cAMP and cGMP with their specific protein kinases showed that both nucleotides are bound by similar forces in the 2', 3' and 5' region, both bases may be bound in syn conformation, but that each base moiety is bound by different molecular interaction, thus leading to the selectivity of the two enzymes. cGMP analogs which possessed strong selectivity for the rapidly exchanging site, but not those selective for the slowly exchanging site, stimulated the binding of [3H]cGMP. Only a few cGMP analogs were more potent than cGMP in stimulating protein kinase activity. The potency of cGMP analogs as stimulators of kinase activity correlated better with the mean binding affinity for both binding sites than with the affinity for either site alone. Two analogs added in combination were synergistic in kinase activation, particularly if one analog was selective for the slowly exchanging site and the other for the rapidly exchanging site. These observations are suggestive that cGMP binding at the rapidly exchanging site stimulates cGMP binding at the slowly exchanging site and that both sites are involved in the activation process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Decreased phosphorylation of a low molecular weight protein by cGMP-dependent protein kinase in variant HL-60 cells resistant to nitric oxide- and cGMP-induced differentiation.

Authors:  J S Scheele; R B Pilz; G Clark; N Gupta; D Loo; P Martis; G R Boss
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

2.  Characterization of cyclic GMP-binding sites of cyclic GMP-dependent protein kinase by rapid filtration assay.

Authors:  M Hirai; S Hashimoto; T Kuno; C Tanaka
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

3.  Potentiation by cyclic GMP of beta-adrenergic effect on Ca2+ current in guinea-pig ventricular cells.

Authors:  K Ono; W Trautwein
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

4.  Cyclic guanosine 3',5'-monophosphate regulates the calcium current in single cells from frog ventricle.

Authors:  R Fischmeister; H C Hartzell
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

5.  The gene product of a Trypanosoma equiperdum ortholog of the cAMP-dependent protein kinase regulatory subunit is a monomeric protein that is not capable of binding cyclic nucleotides.

Authors:  José Bubis; Juan Carlos Martínez; Maritza Calabokis; Joilyneth Ferreira; Carlos E Sanz-Rodríguez; Victoria Navas; José Leonardo Escalona; Yurong Guo; Susan S Taylor
Journal:  Biochimie       Date:  2017-12-27       Impact factor: 4.079

6.  Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.

Authors:  D Pinsky; M Oz; H Liao; S Morris; J Brett; R Sciacca; M Karakurum; M Van Lookeren Campagne; J Platt; R Nowygrod
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 7.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness.

Authors:  R Lane Brown; Timothy Strassmaier; James D Brady; Jeffrey W Karpen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

8.  Nitration of tyrosine 247 inhibits protein kinase G-1α activity by attenuating cyclic guanosine monophosphate binding.

Authors:  Saurabh Aggarwal; Christine M Gross; Ruslan Rafikov; Sanjiv Kumar; Jeffrey R Fineman; Britta Ludewig; Danny Jonigk; Stephen M Black
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

9.  Switching Cyclic Nucleotide-Selective Activation of Cyclic Adenosine Monophosphate-Dependent Protein Kinase Holoenzyme Reveals Distinct Roles of Tandem Cyclic Nucleotide-Binding Domains.

Authors:  Daniel He; Robin Lorenz; Choel Kim; Friedrich W Herberg; Chinten James Lim
Journal:  ACS Chem Biol       Date:  2017-11-21       Impact factor: 5.100

10.  Crystal Structure of PKG I:cGMP Complex Reveals a cGMP-Mediated Dimeric Interface that Facilitates cGMP-Induced Activation.

Authors:  Jeong Joo Kim; Robin Lorenz; Stefan T Arold; Albert S Reger; Banumathi Sankaran; Darren E Casteel; Friedrich W Herberg; Choel Kim
Journal:  Structure       Date:  2016-04-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.